Position in CYTK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$59,633,000
-$30,948,431 QoQ
Shares Held
700,000
-49.1% QoQ
Ownership
0.504%
of shares outstanding
% of Portfolio
0.91%
of 13F equity value
Holder Rank
#47
of 477 holders
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Derivatives in CYTK
reported options exposure · as of Dec 31, 2023CallValue
$112,486,077
CallShares
1,347,300
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Deep Track Capital, LP holds $5,341,997,223 across 58 Biotechnology names. CYTK ranks #30 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IMVT |
Immunovant, Inc.
|
9,341,151 | $359,914,548 | |
| 2 | GPCR |
Structure Therapeutics Inc.
|
4,740,072 | $254,399,664 | |
| 3 | PCVX |
Vaxcyte, Inc.
|
4,300,000 | $249,959,000 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
825,000 | $248,349,750 | |
| 5 | MANE |
Veradermics, Inc
|
2,000,000 | $245,880,000 | |
| 6 | TARS |
Tarsus Pharmaceuticals, Inc.
|
3,666,768 | $230,786,377 | |
| 7 | OCUL |
Ocular Therapeutix, Inc
|
19,686,282 | $193,319,289 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
3,307,481 | $189,254,062 |
All Filings in CYTK
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $59,633,000 | 700,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $90,581,431 | 1,374,320 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $212,032,852 | 3,336,998 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $236,328,000 | 4,300,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $120,596,000 | 3,650,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $123,538,152 | 3,073,853 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $117,600,000 | 2,500,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $33,259,036 | 629,906 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $7,178,579 | 132,495 | Shares | Sole | 2024-08-14 | |
| 2023-12-31 | $24,124,352 | 288,949 | Shares | Sole | 2024-02-14 | |
| 2023-12-31 | $112,486,077 | 1,347,300 | Call | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||